Pacala Mark L
SEC Form 4 insider trading activity
Pacala Mark L has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, Pacala Mark L is listed as Director at Oncology Institute, Inc. Inside the rolling window, Pacala Mark L reported no open-market purchases and 1 open-market sale totaling $200K in TOI.
Companies traded
Other insiders at TOI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$200K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pacala Mark L made?
Pacala Mark L has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Pacala Mark L trade?
Pacala Mark L has filed SEC Form 4 disclosures for 1 company, including TOI.
When was Pacala Mark L's most recent SEC Form 4 filing?
Pacala Mark L's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is Pacala Mark L's total buy and sell value in the current window?
Inside the rolling retention window, Pacala Mark L bought $0 and sold $200K based on SEC Form 4 filings.
What was Pacala Mark L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 TOI shares on 2025-11-18, worth $200K, per SEC Form 4 filings.